OmniLife Named a Finalist for the 2022 Innovation Challenge in Kidney Disease by Lyfebulb and CVS Kidney Care®

OmniLife, a health technology integrated communication, workflow, and care coordination platform focused on transplant hospitals, group practices, and ACOs (e.g., KCCs), has been recognized as a finalist for the 2022 Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes by the teams at Lyfebulb and CVS Kidney Care®, a CVS Health® company. Read more >>